🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSURMOUNT-MMO: tirzepatide for morbid obesity — trial update Page 3

SURMOUNT-MMO: tirzepatide for morbid obesity — trial update

SurmountFan_IN Thu, May 28, 2026 at 7:56 PM 11 replies 436 viewsPage 3 of 3
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
May 29, 2026 at 12:11 AM#11
TrialTracker_MD said:
SURMOUNT-MMO tirzepatide for morbid is not that straightforward in my experience

This is exactly right. TrialTracker_MD articulated what I have been trying to explain to my friends for months. The SURMOUNT-MMO tirzepatide aspect is what made the difference for me.

31 0Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 28 others
Reply Quote Save Share Report
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
May 29, 2026 at 12:28 AM#12

Reading this thread on SURMOUNT-MMO tirzepatide hits close to home. Dad of 2 checking in — I started at 265 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 40 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about SURMOUNT-MMO — take the leap. It was the best health decision I have ever made. ❤️

Last edited: May 29, 2026 at 4:28 AM
9 7NicoleRaleigh, james_edin, FranDenver and 6 others
Reply Quote Save Share Report
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
May 29, 2026 at 12:45 AM#13

KevinCompounds — that is really helpful context on SURMOUNT-MMO tirzepatide. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

48 7ZaraB_AL, JakeSmashed95, NauseaFreeNow and 45 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
May 29, 2026 at 1:02 AM#14

To answer dave_SLC's question specifically:

From a clinical standpoint, SURMOUNT-MMO tirzepatide for is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

Last edited: May 29, 2026 at 6:02 AM
3 21Dr.LeslieOBGYN, MikeNYC_runner
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
May 29, 2026 at 1:19 AM#15

Bookmarked 📌 The SURMOUNT-MMO info in this thread is essential. Coming back to this for sure.

Last edited: May 29, 2026 at 3:19 AM
24 9JessicaM_2024, TomFromTexas, mike.trainer_LA and 21 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register